Dev Medicines Private Limited

Dev Medicines Private Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U51397DL2003PTC118609 Incorporated 22 January 2003 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company healthcare
Data last updated
Revenue · FY 2025
₹9.47 Cr
▲ 173% YoY
Net profit · FY 2025
₹16.23 Lakh
Net margin 1.7%
EBITDA · FY 2025
₹22.27 Lakh
EBITDA margin 2.4%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹7.4 Lakh
Issued & subscribed
Company age
23 yrs
Est. 2003
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Dev Medicines Private Limited

Data last updated:

Dev Medicines Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 22 January 2003 and has been in existence for over 23 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2003PTC118609. Its GSTIN is 07AABCD7595H1ZC (Delhi).

The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹7.4 Lakh. It is led by directors Krishan Kumar and Seema Sardana.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 12/ 26 Lower Ground Floor East Patel Nagar, New Delhi, Delhi, India – 110008.

As per the financials filed for FY 2025, the company reported a revenue of ₹9.47 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹16.23 Lakh (net margin 1.7%) and EBITDA of ₹22.27 Lakh (EBITDA margin 2.4%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 18% over five years.

Court records list 1 case involving the company.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website devson.in.

Company Details of Dev Medicines Private Limited
CIN U51397DL2003PTC118609
Registration Number 118609
Incorporation Date 22 January 2003
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
    Locked
  • Registered Address
    12/ 26 Lower Ground Floor East Patel Nagar, New Delhi, Delhi, India – 110008
  • Industry
    Healthcare, Medical Equipment Retail & Distribution
Comprehensive company report
Dev Medicines Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Dev Medicines Private Limited report

Financials, compliance, directors, charges, ownership and filings for Dev Medicines Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Dev Medicines Private Limited

The main business activity of Dev Medicines is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Dev Medicines Private Limited FY 2025 filings available

Dev Medicines Private Limited reported revenue of ₹9.47 Cr (up 173% YoY) for FY 2025.

Revenue · FY 2025
₹9.47 Cr ▲ 173%
Net profit · FY 2025
₹16.23 Lakh margin 1.7%
EBITDA · FY 2025
₹22.27 Lakh margin 2.4%

Compounded Annual Growth Rate (CAGR) of Dev Medicines Private Limited

Revenue CAGR growth
1 year
▲ 173%
3 years · compounded
▲ 19%
5 years · compounded
▲ 18%
EBITDA CAGR growth
1 year
▲ 34%
3 years · compounded
▲ 18%
5 years · compounded
▼ 16%

Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 173% growth in the latest year. EBITDA rose 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Dev Medicines Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹22.27 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹16.23 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Dev Medicines Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin2.4%••••••••••••••••
Net Profit Margin1.7%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Dev Medicines are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Dev Medicines Private Limited

Dev Medicines Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
SW Health Care Private Limited₹9.5 Cr (FY 2024)••••••••-30.0%••••Delhi, India
Skyquest Technology Consulting Private Limited₹9.49 Cr (FY 2024)••••••••37.0%••••Ahmedabad, Gujarat, India
Bayu Healthcare Private Limited₹9.49 Cr (FY 2025)••••••••12.0%••••Lucknow, Uttar Pradesh, India
Napo Exports Private Limited₹9.48 Cr (FY 2025)••••••••-6.0%••••Indore, Madhya Pradesh, India
Shree Bihariji Distributors Private Limited₹9.48 Cr (FY 2025)••••••••2.0%••••Kolkata, West Bengal, India
Dev Medicines Private Limited this company₹9.47 Cr (FY 2025)••••••••173.0%••••New Delhi, Delhi, India
Sign Pharma Trade Services Private Limited₹9.46 Cr (FY 2025)••••••••-7.0%••••Mumbai, Maharashtra, India
DJ Lifescience Private Limited₹9.46 Cr (FY 2020)••••••••-32.0%••••Ahmedabad, Gujarat, India
New Medical (Agartala) Pvt Ltd₹9.45 Cr (FY 2025)••••••••-6.0%••••Kolkata, West Bengal, India
Advani Pvt Ltd₹9.45 Cr (FY 2025)••••••••-6.0%••••Kolkata, West Bengal, India
Pace Techno Private Limited₹9.45 Cr (FY 2024)••••••••301.0%••••Pune, Maharashtra, India

Peers are the five companies nearest above and the five nearest below Dev Medicines by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Dev Medicines Private Limited

Dev Medicines Private Limited is audited by NAVEEN CHUGH & CO for the financial year 2021.

NameStatusAppointment DateCessation Date
NAVEEN CHUGH & COLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Dev Medicines Private Limited

Dev Medicines has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Krishan KumarDirector22 Jan 200323 Years 8 MonthsCurrent
Seema SardanaDirector22 Jan 200323 Years 8 MonthsCurrent

Ownership and Shareholding of Dev Medicines Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Dev Medicines Private Limited

Dev Medicines Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Dev Medicines Private Limited

Employment history and EPFO contributions of people linked to Dev Medicines.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Dev Medicines Private Limited

Dev Medicines Private Limited has 2 board changes on record since 2003: 2 appointments. The latest: Krishan Kumar was appointed as Director on 22 Jan 2003.

AGM
Dev Medicines Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Dev Medicines Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Appointed
Krishan Kumar was appointed as Director.
Appointed
Seema Sardana was appointed as Director.
Incorporation
22 Jan 2003
Dev Medicines Private Limited was registered on 22 Jan 2003 with Roc Delhi Ii & aged 23 years 8 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Dev Medicines Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Dev Medicines Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Dev Medicines Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Dev Medicines Private Limited

Dev Medicines has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AABCD7595H1ZCDelhiActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Dev Medicines Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dev Medicines Private Limited

Dev Medicines is an active private limited company based in New Delhi, Delhi, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 22 January 2003 (23+ years old) and is registered under CIN U51397DL2003PTC118609.

Dev Medicines reported revenue of ₹9.47 Cr for FY 2025 (up 173% YoY).

Dev Medicines has 2 current directors:

Dev Medicines reported a net profit of ₹16.23 Lakh (net margin 1.7%) and EBITDA of ₹22.27 Lakh (EBITDA margin 2.4%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Dev Medicines is 19% over three years and 18% over five years. In the latest year (FY 2025) revenue rose 173%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Dev Medicines is 07AABCD7595H1ZC, registered in Delhi.

The CIN (Corporate Identification Number) of Dev Medicines is U51397DL2003PTC118609. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Dev Medicines has 1 court case on record.

Dev Medicines was incorporated on 22 January 2003, making it 23+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Dev Medicines by revenue are SW Health Care Private Limited, Skyquest Technology Consulting Private Limited, Bayu Healthcare Private Limited, Napo Exports Private Limited, Shree Bihariji Distributors Private Limited and 5 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution).

Krishan Kumar was appointed as Director on 22 Jan 2003. Seema Sardana was appointed as Director on 22 Jan 2003.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available